Qianjiang Yongan Pharmaceutical Co Ltd Capital Reinvestment Ratio
Qianjiang Yongan Pharmaceutical Co Ltd capital reinvestment ratio. Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Capital Reinvestment Ratio of 0.20x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥58.18 Million) in capital expenditures (CN¥11.85 Million). Check 002365 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
Capital reinvestment ratio of Qianjiang Yongan Pharmaceutical Co Ltd from 2006 to 2024. This chart tracks Qianjiang Yongan Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods. Also explore how fast is Qianjiang Yongan Pharmaceutical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Qianjiang Yongan Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2006–2024)
Qianjiang Yongan Pharmaceutical Co Ltd capital reinvestment ratio by year from 2006 to 2024. For the full cash flow conversion analysis, see 002365 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.12x | CN¥105.71 Million | CN¥118.04 Million | ▲ +125.9% |
| 2023 | 0.49x | CN¥244.26 Million | CN¥120.74 Million | ▲ +28.4% |
| 2022 | 0.38x | CN¥387.28 Million | CN¥149.07 Million | ▼ -37.8% |
| 2021 | 0.62x | CN¥101.81 Million | CN¥63.05 Million | ▲ +22.6% |
| 2020 | 0.51x | CN¥206.66 Million | CN¥104.41 Million | ▼ -9.9% |
| 2019 | 0.56x | CN¥239.55 Million | CN¥134.39 Million | ▼ -34.6% |
| 2018 | 0.86x | CN¥314.02 Million | CN¥269.50 Million | ▼ -41.5% |
| 2017 | 1.47x | CN¥197.32 Million | CN¥289.47 Million | ▲ +209.0% |
| 2016 | 0.47x | CN¥84.53 Million | CN¥40.13 Million | ▼ -1.8% |
| 2015 | 0.48x | CN¥70.61 Million | CN¥34.12 Million | ▼ -81.6% |
| 2014 | 2.63x | CN¥19.26 Million | CN¥50.69 Million | ▲ +67.6% |
| 2013 | 1.57x | CN¥63.65 Million | CN¥99.93 Million | ▼ -7.6% |
| 2012 | 1.70x | CN¥70.75 Million | CN¥120.18 Million | ▼ -37.5% |
| 2011 | 2.72x | CN¥91.23 Million | CN¥248.03 Million | ▲ +14.6% |
| 2010 | 2.37x | CN¥44.06 Million | CN¥104.52 Million | ▲ +87.9% |
| 2009 | 1.26x | CN¥36.43 Million | CN¥45.98 Million | ▲ +177.0% |
| 2008 | 0.46x | CN¥158.47 Million | CN¥72.19 Million | ▼ -54.2% |
| 2007 | 0.99x | CN¥61.08 Million | CN¥60.77 Million | ▲ +75.1% |
| 2006 | 0.57x | CN¥31.11 Million | CN¥17.68 Million | — |